| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |